Introduction {#Sec1}
============

One million particles per patient may be infused daily in an intensive care setting, where a potential risk appears against the background of debilitation and impaired host responses \[[@CR1], [@CR2]\]. Mechanisms of particle damage to various organs have been postulated, including effects on microcirculation causing thrombi and granuloma formation \[[@CR3]--[@CR5]\]. Use of in-line filtration almost completely prevents particulate infusion \[[@CR6]\]. Recent studies have evaluated the clinical effect of in-line filtration and showed significant reduction in thrombophlebitis \[[@CR7]\] and a trend towards reduction of complications in neonates such as sepsis, thrombosis, and necrotizing enterocolitis \[[@CR8]\].

To evaluate the effects of microfilters in the pediatric intensive care unit (PICU), we carried out detailed examinations of filters after their use. Electron microscopy (EM) visualized particles adhering to the membrane, and energy dispersion spectroscopy (EDX) revealed their chemical compositions \[[@CR9]\]. Based on these data immune-modulating effects on human umbilical vein endothelial cells (HUVEC) and murine macrophages (RAW 264.7) were analyzed in vitro.

Materials and methods {#Sec2}
=====================

Prior to this study, the infusion regiment in the PICU was optimized to prevent precipitation and incompatibilities using a computer-based analysis. Solutions and therapeutics were prepared according to the manufacturers' recommendations. Approval by the ethics committee and parental consent were obtained.

EM and EDX {#Sec3}
----------

Twenty-five Pall ELD96LLCE/NEO96E filters with 0.2 μm pore size (Pall, Dreieich, Germany) were analyzed. Twenty filters from nine patients were randomly chosen after 72 h. Five unused filters served as controls (see Table 1, ESM). For detailed information see ESM.

Cell culture {#Sec4}
------------

To simulate the in vivo situation, glass particles (2--20 μm) were chosen to mimic the silicon content of particles found on the filters. Contamination with lipopolysaccharide (LPS) was excluded. Inflammatory effects were analyzed on RAW 264.7 (gamma NO-, ATCC CRL-2278) and HUVEC (CC2517). Cytotoxic particle load was determined by release of adenylatkinase (ToxiLight test) and lactate-dehydrogenase (LDH-cytotoxicity test). Experiments were performed at subtoxic loads. Cells were incubated with glass particles at contents from 0 to 500 μg/ml. Release of interleukin 1-beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor alpha (TNFα) was measured after 4, 8, and 24 h with ELISA kits for IL-1β (DY201), IL-6 (DY406), IL-8 (DY208), and TNFα (DY410; all kits by R&D Duoset).

Cells were additionally incubated with 1 μg/ml LPS, and HUVEC cells with 1 ng/ml TNFα as well. Results of ELISA are given as the median of repeated determinations. ToxiLight test results reflect the mean of four trials and considered values within three standard deviations of the controls as nontoxic. Statistics were processed by Dunnett's test \[[@CR10]\].

Results {#Sec5}
=======

EM and EDX analysis {#Sec6}
-------------------

The average number (range) of particles on the surface of the negative controls was 45.6 particles/cm^2^ (6--93 particles/cm^2^). Used filters showed a mean of 550 particles/cm^2^ (8--1,993 particles/cm^2^), which was significantly higher than the mean particle load of controls (*P* \< 0.001).

Particle size ranged from 5 to \>100 μm with the majority between 5 and 50 μm. EDX analysis detected silicon, carbon, oxygen, sodium, chloride, potassium, calcium, magnesium, iron, and aluminum. Phosphorus, thallium, fluorine, chromium, copper, zinc, sulfur, barium, and nickel were seldom found. Only carbon and oxygen may be part of the membrane itself. Gold was added during preparation. Silicon was the most frequently detected element in analysis of individual particles. These particles were notable for their angular shape and crystalline appearance (Fig. [1](#Fig1){ref-type="fig"}a, b).Fig. 1Particle (**a**) with corresponding EDX analysis (**b**) and conglomerate (**c**) found by electron microscopy on the surface of different filters. Presented filter (**a**) was used for the application of bolus injections of multiple different therapeutics via a central venous line. The size of the particle is approximately 40 × 20 μm. It shows the representative angular shape and crystalline appearance. In addition to the large particle, many smaller particles and the incipient blockage of the filter membrane are apparent. The corresponding EDX (**b**) revealed silicon as the major chemical element. The second filter (**c**) was used for high osmolar parenteral nutrition (\>1,300 mosmol/l) via a central venous catheter in a 4-month-old infant after liver transplantation. The EDX analysis revealed carbon, sodium, chloride, potassium, selene, silicon, and phosphate as components of the conglomerate

Fifty percent of analyzed filters showed conglomerates on the surfaces, containing uncountable numbers of particles. Figure [1](#Fig1){ref-type="fig"}c shows a conglomerate, detected on a filter used for parenteral nutrition and heparin (filter 12, Table 1, ESM). Parenteral nutrition was highly concentrated with an osmolarity \>1,300 mosm/l. EDX analysis revealed different elements as components of the conglomerate (e.g., carbon, sodium, potassium). It demonstrates the spectrum of elements and is representative of other analyzed particles. Results of particle counts and data of the applied fluids/therapeutics are shown in Table 1 of the ESM. Data suggest a correlation between the complexity of the infusion regiment and the particle load (Fig. 1, ESM).

Cell culture (HUVEC/RAW 264.7) {#Sec7}
------------------------------

### Cytotoxicity {#Sec8}

ToxiLight and LDH-cytotoxicity tests found that particle loads \>500 μg/ml were toxic in RAW 264.7 and HUVEC. For detailed information on cytotoxicity tests, see ESM.

**HUVEC and IL-8** After incubation of HUVEC with glass particles, IL-8 increased significantly in samples of 300 μg (*P* \< 0.05) and 500 μg (*P* \< 0.01) particles/ml. Additional stimulation of HUVEC with 1 μg/ml LPS or 1 ng/ml TNFα led to a 10-fold increase in IL-8 in samples incubated with particle concentrations above 300 μg/ml. Samples with particle dilution of 10 μg/ml and above showed significant suppression of IL-8 at 4 and 8 h after incubation with LPS (Fig. 2, ESM). Increased IL-8 levels were detected for 300 and 500 μg/ml (data not shown).

**HUVEC and IL-1β** After 8 and 24 h incubation, concentrations of IL-1β were significantly suppressed (*P* \< 0.05) (Fig. [2](#Fig2){ref-type="fig"}). Adding 1 μg/ml LPS did not change the IL-1β secretion. Also stimulation of HUVEC with 1 ng TNFα/ml revealed no significant variation after 4 and 8 h. Samples could not be analyzed for IL-1β concentration after 24 h since over 80% of cells died.Fig. 2Interleukin-1beta concentration (pg/ml) after 4, 8 and 24 h incubation period of HUVEC with different glass particle concentrations. After 8 h incubation with glass particles the release of interleukin-1beta was significantly reduced independent from particle content. Values are mean of four separate assays ±standard deviation of all samples. \**p* \< 0.05; \*\**p* \< 0.01

**RAW 264.7 and TNFα** In macrophages, control samples from 4 to 24 h showed a high spontaneous release of TNFα. Increasing the particle load resulted in reduction of TNFα after 4--8 h. Only after incubation of 24 h was a significant dose-related stimulation detected (*P* \< 0.01) (data not shown).

**RAW 264.7 and IL-6** Significant suppression of IL-6 concentration occurred after an incubation period of 8 h with a particle load of 10 μg/ml. In the remaining samples, incubation of RAW with glass particles did not show any dose-related release of IL-6. Incubation with 1 μg/ml LPS for 4 h revealed a doubling of IL-6 concentration without any dose-related effects of particles. After 24 h a significant reduction of IL-6 was detected (data not shown).

Discussion {#Sec13}
==========

Our results confirmed the existence of particulate contamination in infusions despite a stringent infusion regime in the PICU. Different contents of particles were found, and data suggest that particle exposure is dependent on the complexity of infusions and medications. These findings are in keeping with the results of Mehrkens et al. \[[@CR1]\], who showed that bolus injections mainly increase particulate contamination of the administered fluids.

Considering the detection limit of 5 μm, the detected amount underestimates the particle exposure. Fifty percent of the analyzed membranes showed conglomerates containing uncountable numbers of particles. Smaller particles were retained in the three-dimensional meshwork of the membrane and were disregarded. Most particles were between 5 and 50 μm, which is more than the diameter of lung and tissue capillaries \[[@CR11]\] and may cause obstruction. This supports the findings of Puntis et al. \[[@CR4]\] that particles cause granulomatous arteritis after parenteral nutrition as demonstrated by post-mortem study of 73 infants.

In accordance with other authors, we identified silicon as a major chemical component \[[@CR12]\], which originates mainly from storage in glass ampoules \[[@CR13]\].

In addition to mechanical obstruction, inflammatory response of different organ systems after particle exposure is possible \[[@CR3], [@CR14], [@CR15]\]. To mimic these mechanisms, we exposed macrophages and endothelial cells to particles similar to those found on the filters. Our experiments with endothelial cells showed significant suppression of IL-1β after incubation with particles for 8 and 24 h. Comparable results were assessed for IL-8. This effect was aggravated by LPS. In macrophages, different particle loads suppressed the secretion of TNFα. Similar effects were evident for IL-6, which was significantly suppressed after 8 h incubation. Increased IL-8 was found after incubation with 300--500 μg/ml particles. This was probably due to cytotoxicity as was seen for comparable particle contents in pre-tests.

Previously published data suggest an activation of the immune system by particles \[[@CR15]\]. In contrast, our experiments showed a reduced cytokine release. Immune paralysis is an accepted phenomenon in sepsis or after ischemia or trauma, as confirmed by clinical and experimental studies \[[@CR16]--[@CR19]\]. The importance of the exact regulation of the chemokine release and the balance of pro-inflammatory and anti-inflammatory mediators in this phase of the disease is not exactly clear. Small changes may have an influence and alter the process of overcoming the disease. Foreign particles may interfere with this phase of the disease when the patient is especially vulnerable.

Lehr et al. \[[@CR5]\] demonstrated that stress increases the harmful effects of particles. Their animal model revealed a reduction in capillary density in post-ischemic muscles after particle infusion, in cases without preceding ischemia, no change in density was detectable.

A documented benefit of filtration is the prevention of infusion phlebitis \[[@CR7]\]. Less information exists for the influence of filtration on severely ill patients. One single-center trial on 88 preterm newborns showed a trend toward decreased morbidity in the treatment group \[[@CR8]\]. However, the incidence of sepsis could not be reduced by in-line filtration \[[@CR20]\].

According to the data of a preceding analysis, 70% of our PICU patients were provided with a central-venous line with three lumina for standardized infusion therapy. Despite this standard, our examinations demonstrate that particle exposure continues to be an unpredictable risk for patients receiving infusion therapy.

Review of literature and our data suggest that particles are capable of modulating cytokine secretion and may exert harmful effects beyond mechanical obstruction. Whether particles affect the outcome of PICU patients has to be further evaluated.
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